> India's Advinus says it is preparing to launch clinical trials for a new diabetes therapy which constitutes a new class of drug, says CEO Rashmi Barbhaiya. "There are no drugs of a similar nature in the market. The nearest one to the type of drug we are trying to develop is in the clinical trial stage," Barbhaiya, CEO of Advinus. Article
> Vanda Phaarmaceuticals is facing a critical moment as an FDA decision looms for its schizophrenia drug. Report
> Fast-growing Acceleron Pharma has inked a deal to lease a third facility in Cambridge, MA. Article
> Rexahn announced positive data for Zoraxel, a Phase IIa clinical study for the treatment of ED. Release
> China Aoxing Pharmaceutical says it has received a new production license for Isosorbide Mononitrate Injection from the China State Food and Drug Administration for treatment of angina pectoris, myocardial infarction, of chronic congestive heart failure, pulmonary hypertension and related coronary artery disease. Report
> Circ Pharma and Elan have forged a pact to develop a chronotherapeutic formulation of Tramadol for the treatment of moderate to moderately severe pain. Release
> Cougar Biotechnology has launched a Phase III clinical trial of its lead drug candidate CB7630 (abiraterone acetate) in patients with chemotherapy-naïve castration-resistant prostate cancer. Report
> Don't put only one flu drug in your stockpile basket, scientists are saying. To keep antiviral resistance at bay, countries are better off with more than one option. Report
> A sign of the times: There's a new website specifically for laid-off pharma types. Started by a group of "current or former pharma professionals" who've found/are looking for new jobs--and who presumably wish to remain anonymous--the site offers a bunch of advice, resources and inspirational articles about ex-pharma-ites who've successfully switched to new careers. Report
> GlaxoSmithKline and Roche have been reduced to playing flu-drug traffic cop. Because the worried well are snapping up drugs all over the world, prompting shortages in some places, the drugmakers are strategically allocating their stocks. Report
> The OnCore clinical research management system "sports a sleek new user interface" and incorporates hundreds of enhancement requests provided by 20 research organizations, according to developer PercipEnz Technologies, a maker of clinical and translational research management software. Report
> The Human Genome Project and advances in personalized medicine would not have been possible without "leaps" made in information technology, says former House Majority Leader Richard Gephardt. To keep the innovation coming, business and government leaders need to understand that tomorrow's scientists require a nurturing that goes beyond textbooks and traditional teaching methods. Report
> Disease diagnostics developer Celera is using the InforSense translational research solution to identify genetic markers indicating increased risk of coronary heart disease. The solution allows researchers to integrate internal molecular data sources and public data sources, speeding the marker-identification process. Celera report
> Concerns about regulatory acceptance, new techniques, and access to clinical endpoint data represent the top barriers to the implementation of adaptive clinical trial design, according to a recent survey of more than 500 biopharma professionals. Report
And Finally... UC Irvine researchers have found that eating fat-rich foods triggers the formation of long-term memories of that activity. Release